OFM financial systems business (FMS) FMS user fees RE-architecture and electronic invoicing implementation

Ended Awarded Last action

Contract number
75F40122F19012
Awardee
Awarding agency
Obligated
$2,640,657

Award facts

Contract value 100% obligated
$2,640,656.71 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Calverton, MD 20705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $2,640,657

About this award

This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority-Owned, Self-Certified Small Disadvantaged Business, and Subcontinent Asian-American Owned IT services and management consulting company. The $2,640,656.71 contract calls for Equinoxys to provide architecture, implementation, and maintenance services for the FDA's Financial Management System (FMS) user fee re-architecture and electronic invoicing initiatives. The work will be performed in Calverton, Maryland and is not associated with a set-aside program. Equinoxys has an extensive track record of supporting the FDA's Unified Financial Management System (UFMS) and other mission-critical financial systems through IT modernization, data analytics, and professional services. This contract award leverages Equinoxys' expertise to enhance the FDA's user fee management capabilities and transition to more automated, cloud-based financial processes.

Subawards

Subcontractor Amount Awarded
Parab Consulting Group Inc. BUSINESS PROCESS IMPROVEMENT/STRATEGIC PLANNING Business and Technology consulting services including implementation and system integration of systems,… $160,000

Quick answers

Who was awarded contract 75F40122F19012?

75F40122F19012 was awarded to Equinoxys Inc. by Food and Drug Administration (Department of Health and Human Services) on February 1, 2022.

How much is contract 75F40122F19012 worth?

The government has obligated $2,640,657 on 75F40122F19012.

Is contract 75F40122F19012 an order under another contract?

Yes. 75F40122F19012 is a BPA call under GS35F0331V-75F40118A10047, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40122F19012 competed?

The extent of competition for 75F40122F19012 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award